Dupilumab in Atopic Dermatitis Linked to Reduced Irritable Bowel Syndrome Risk: A Real-World Cohort Study. Article uri icon

Overview

publication date

  • June 25, 2025

Identity

Scopus Document Identifier

  • 105008893054

Digital Object Identifier (DOI)

  • 10.1111/all.16637

PubMed ID

  • 40560741

Additional Document Info

volume

  • 80

issue

  • 9